Clinical Trial Update: Omitting CTV for Primary Tumor in LS-SCLC [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating omitting the clinical target volume (CTV) for the primary tumor in limited-stage small cell lung cancer during radiothe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: SCLC, Limited Stage, Radiation Exposure | Phase 3 | Status: RECRUITING